Updated Jul 16, 2026
Shah Sujal has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Shah Sujal is an individual identified in public SEC filings as affiliated with Tvardi Therapeutics, Inc. The most recent filing available within the provided context is dated 2026-06-11 and lists Sujal in connection with Tvardi Therapeutics. Publicly disclosed biographical details such as his exact role (e.g., officer, director, or other insider), background, education, and career history are not provided in the context of the SEC filing. There is no public record in the provided context indicating that Sujal has died as of the latest filing date.
| Role | Insider |
|---|---|
| Notability | 40/100 |
Shah Sujal is an individual identified in public SEC filings as affiliated with Tvardi Therapeutics, Inc. The most recent filing available within the provided context is dated 2026-06-11 and lists Sujal in connection with Tvardi Therapeutics. Publicly disclosed biographical details such as his exact role (e.g., officer, director, or other insider), background, education, and ca…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Shah Sujal profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.